Monica Otto

Government, Health and Not for Profit


Pubblicazioni recenti

JOMMI C., ARMENI P., BERTOLANI A., COSTA F., OTTO M. The future of Funds for Innovative Medicines: results from a Delphi Study Global & Regional Health Technology Assessment: Italian; Northern Europe and Spanish, 2021, vol.8, pp.22-28
JOMMI C., ARMENI P., COSTA F., BERTOLANI A., OTTO M. Implementation of Value-based Pricing for Medicines Clinical Therapeutics, 2020, vol.42, no. 1, pp.15-24
OTTO M., ARMENI P., JOMMI C. Variations in non-prescription drug consumption and expenditure: Determinants and policy implications Health Policy, 2018, vol.122, no. 6, pp.614-620
OTTO M., Pillarella C., JOMMI C. The Economic Impact of a Switch From Prescription-Only to Non-prescription Drugs in Italy Frontiers in Pharmacology, 2018, vol.9, no. 1069
ARMENI P., COSTA F., OTTO M., Amoroso N., JOMMI C. La rendicontazione e la remunerazione dei farmaci Mecosan, 2016, vol.25, no. 98, pp.61-82
ARMENI P., JOMMI C., OTTO M. The simultaneous effects of pharmaceutical policies from payers' and patients' perspectives: Italy as a case study The European Journal Of Health Economics, 2016, vol.17, no. 8, pp.963-977

Articoli correlati

Hospital Management during pandemic crisis: Lessons Learn...
Tempo richiesto 1 ora